February 17, 2025 - 13:34

The name Francis Yao Selormey has resurfaced amidst discussions surrounding the declaration of former Minister for Finance, Ken Ofori-Atta, as a wanted fugitive by the Office of the Special Prosecutor. Selormey, who served as the deputy finance minister under former President Jerry Rawlings, is known for his tumultuous time in office and the legal challenges he faced thereafter.
In recent years, Selormey's health has been a topic of concern, particularly as he spent significant time in jail, relying on a pacemaker and an oxygen tank. His experience highlights the often harsh realities faced by public officials embroiled in legal battles and the impact of such situations on their personal well-being.
As the political landscape evolves, Selormey's story serves as a reminder of the complexities surrounding governance and accountability in the country. The ongoing developments in the case against Ofori-Atta may further shape discussions about past administrations and their legacies.
March 27, 2026 - 07:31
Asian stocks mostly lower after Wall Street's worst day since start of Iran warFinancial markets across the Asia-Pacific region traded mostly lower on Friday, mirroring a severe downturn on Wall Street. The negative sentiment stemmed from growing investor doubts over a...
March 26, 2026 - 20:50
Better Home & Finance, Coinbase to offer mortgage backed by cryptocurrenciesA new financial partnership is bridging the worlds of digital assets and real estate. A novel mortgage program will allow prospective homebuyers to leverage their cryptocurrency investments to...
March 26, 2026 - 05:31
Is Gold a Smart Investment for Your 2026 Portfolio?As investors look ahead to 2026, many are questioning whether gold deserves a place in their financial strategy. Historically, the precious metal has been revered as a safe-haven asset, often...
March 25, 2026 - 01:51
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial ResultsPOMPANO BEACH, Fla., March 24, 2026 – BioStem Technologies, Inc., a leader in regenerative medicine, has released its financial results for the fourth quarter and full year ended December 31,...